Powerful drug companies, like Wyeth, promoted their HRT meds Premarin and Prempro to doctors and heavily targeted older women with their commercials. They hired respectable figures, like actress Lauren Hutton, to announce her support. “There’s nothing more important than protecting your health,” she said. “Believe me, the time to protect your future is now.”

Another ad showed an actress playing the role of a doctor: “When considering menopause, consider the entire body of evidence,” she said.

An ironic statement, really, when you consider the evidence that was beginning to mount against HRT in the years those ads were running, data that Wyeth kept under wraps to protects its billion-dollar empire. It wasn’t until the Women’s Health Initiative (WHI) began to uncover shocking evidence about HRT that the world became privvy to it.

WHI, which was studying the causes of mortality and morbidity in menopausal and post-menopausal women, quickly halted its study on hormone therapy in 2002 when it found that women who took the drugs were at much greater risk of developing breast cancer. It also showed that women who took HRT were at an increased risk of heart attack, stroke and blood clots, and that there was no evidence to support HRT manufacturers’ claim that HRT protected women against dementia.

Now victims are finally having their day in court. Two recent lawsuits filed against Wyeth by two women who were diagnosed with breast cancer following use of HRT, have resulted in a combined $110 million judgment against the Wyeth. More victims will likely see justice soon, as another 10,000-plus other product liability suits have been filed over the HRT drugs across the country.

Source: New York Times

SOURCE: Hormone Replacement Therapy › HRT ads built trust, but breast cancer diagnoses changed opinions